Intercept Pharmaceuticals vs Moderna, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $447 M for Intercept Pharmaceuticals, 202 times as much (market caps of Jul 30, 2023 for Intercept Pharmaceuticals and Oct 30, 2026 for Moderna, Inc.). Intercept Pharmaceuticals's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.
- Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $286 M for Intercept Pharmaceuticals in the year to December 2022.
- Intercept Pharmaceuticals made a net profit of $222 M, while Moderna, Inc. made a net loss of $2.8 B.
- Intercept Pharmaceuticals keeps more of each dollar of sales: a net margin of 77.6% against -145.2% for Moderna, Inc.
- Moderna, Inc. employs more people: 4,700 against 437 at Intercept Pharmaceuticals. Each employee brings in about $653,799 of revenue at Intercept Pharmaceuticals and $413,617 at Moderna, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Intercept Pharmaceuticals ICPT | Moderna, Inc. MRNA · #274 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2002 | 2010 |
| Size | ||
| Market cap | $447 M* | $90.1 B |
| Revenue | $286 M | $1.9 B |
| Net income | $222 M▲ best | $-2.8 B |
| Employees | 437 | 4,700 |
| Valuation | ||
| Price to sales | — | 35.7× |
| Price to book | — | 10.4× |
| Free cash flow yield | — | -2.3% |
| Profitability | ||
| Gross margin | — | 55.4% |
| Operating margin | — | -158.1% |
| Net margin | — | -145.2% |
| Return on equity | — | -28.9% |
| Growth | ||
| Revenue growth | — | -39.9% |
| Revenue growth, 3 years a year | — | -53.4% |
| Financial strength | ||
| Debt to equity | — | 0.1× |
| Cash | ||
| Free cash flow margin | — | -106.2% |
| Shareholder returns | ||
| Shareholder yield | — | 0.0% |
| Strength scores | ||
| Piotroski F-score | — | 3 of 9 |
| Altman Z-score zone | — | safe |
| Data as of | Market cap Jul 2023 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, Intercept Pharmaceuticals or Moderna, Inc.?
Moderna, Inc. is the larger company by market value: $90.1 B against $447 M for Intercept Pharmaceuticals, 202 times as much (market caps of Jul 30, 2023 for Intercept Pharmaceuticals and Oct 30, 2026 for Moderna, Inc.). Intercept Pharmaceuticals's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.
Which makes more money, Intercept Pharmaceuticals or Moderna, Inc.?
Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $286 M for Intercept Pharmaceuticals in the year to December 2022. Intercept Pharmaceuticals made a net profit of $222 M, while Moderna, Inc. made a net loss of $2.8 B.
Which is more profitable, Intercept Pharmaceuticals or Moderna, Inc.?
Intercept Pharmaceuticals keeps more of each dollar of sales: a net margin of 77.6% against -145.2% for Moderna, Inc.
Which has more employees, Intercept Pharmaceuticals or Moderna, Inc.?
Moderna, Inc. employs more people: 4,700 against 437 at Intercept Pharmaceuticals. Each employee brings in about $653,799 of revenue at Intercept Pharmaceuticals and $413,617 at Moderna, Inc.